🇺🇸 Metafolin in United States

31 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cryptorchism — 7 reports (22.58%)
  2. Small For Dates Baby — 6 reports (19.35%)
  3. Foetal Exposure During Pregnancy — 3 reports (9.68%)
  4. Maternal Exposure During Pregnancy — 3 reports (9.68%)
  5. Anxiety — 2 reports (6.45%)
  6. Arthralgia — 2 reports (6.45%)
  7. Asthenia — 2 reports (6.45%)
  8. Blood Glucose Increased — 2 reports (6.45%)
  9. Blood Thyroid Stimulating Hormone Decreased — 2 reports (6.45%)
  10. Blunted Affect — 2 reports (6.45%)

Source database →

Other Dermatology approved in United States

Frequently asked questions

Is Metafolin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Metafolin in United States?

University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.